The 2018 American Society of Clinical Oncology/American Association of Pathologists Detection Guide and 2019 Chinese breast cancer HER-2 Detection Guide regulate the IHC staining requirements and the interpretation of IHC and ISH result (Wolff et al., 2018). Here, ERBB2 is linked to breast carcinoma.